KK
Kondalarao Kota
About Kondalarao Kota
Data last updated:
Kondalarao Kota is a Director at Vijaya Sai Laboratories India Private Limited (since 2012). The company operates in Pharma. Vijaya Sai Laboratories India Private Limited reported revenue of ₹33.90 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Vijaya Sai Laboratories India Private Limited U24100TG2010PTC069188 | Director | 22 Sep 2012 | 2010 | ₹33.90 Cr (FY 2025) | Active |
Board colleagues of Kondalarao Kota
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bhaskar Gupta Kandukuri | 02021086 | Vijaya Sai Laboratories India Private Limited | Additional Director |
| Mohan Rao Srungavarapu | 06380945 | Vijaya Sai Laboratories India Private Limited | Director |
| Narasinga Rao Kandra | 06380942 | Vijaya Sai Laboratories India Private Limited | Managing Director |
| Parikshit Sushilkumar Jain | 00763166 | Vijaya Sai Laboratories India Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kondalarao Kota
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kondalarao Kota
Kondalarao Kota currently holds 1 directorship: Vijaya Sai Laboratories India Private Limited (Director, since 22 Sep 2012, revenue ₹33.90 Cr (FY 2025)).
Kondalarao Kota was first appointed on 22 Sep 2012 as Director at Vijaya Sai Laboratories India Private Limited.
The current boards of Kondalarao Kota's companies include Bhaskar Gupta Kandukuri (Vijaya Sai Laboratories India Private Limited), Mohan Rao Srungavarapu (Vijaya Sai Laboratories India Private Limited), Narasinga Rao Kandra (Vijaya Sai Laboratories India Private Limited), Parikshit Sushilkumar Jain (Vijaya Sai Laboratories India Private Limited).